The Cooper Companies, Inc. (FRA:CP60)

Market Cap	13.98B -24.5%
Revenue (ttm)	3.55B +5.1%
Net Income	325.04M -4.4%
EPS	1.62 -4.6%
Shares Out	n/a
PE Ratio	43.02
Forward PE	18.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	8
Open	71.00
Previous Close	70.50
Day's Range	71.00 - 71.00
52-Week Range	54.00 - 87.00
Beta	n/a
RSI	59.55
Earnings Date	Mar 5, 2026

About The Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor...

• Industry: Ophthalmic Goods
• Founded: 1958
• Employees: 15,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CP60

Financial Performance

In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.

Financial numbers in USD